#treatment — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #treatment, aggregated by home.social.
-
U.S. FDA Grants Accelerated Approval to Bayer’s HYRNUO® (sevabertinib) as a First-Line Targeted Therapy for Patients with HER2-Mutated Non-Small Cell Lung Cancer
First-line approval of HYRNUO® (sevabertinib) for patients with advanced HER2-mutated non-small cell lung cancer (NSCLC) follows U.S. Food…
#Germany #DE #Europe #EU #Europa #Bayer #acceleratedapproval #adversereactions #FDA #HYRNUO #LungCancer #non-smallcelllungcancer #treatment-naïvepatients
https://www.europesays.com/germany/101101/